5-chloro-N-[4-[[3-(2,4-difluorophenyl)-2-oxobenzimidazol-1-yl]methyl]cyclohexyl]-2-methylpyridine-3-carboxamide

C27H25ClF2N4O2 — CID 146172355

IUPAC5-chloro-N-[4-[[3-(2,4-difluorophenyl)-2-oxobenzimidazol-1-yl]methyl]cyclohexyl]-2-methylpyridine-3-carboxamide
SMILESCc1ncc(Cl)cc1C(=O)NC1CCC(Cn2c(=O)n(-c3ccc(F)cc3F)c3ccccc32)CC1
InChIInChI=1S/C27H25ClF2N4O2/c1-16-21(12-18(28)14-31-16)26(35)32-20-9-6-17(7-10-20)15-33-24-4-2-3-5-25(24)34(27(33)36)23-11-8-19(29)13-22(23)30/h2-5,8,11-14,17,20H,6-7,9-10,15H2,1H3,(H,32,35)
InChIKeyFNWRGOIAYKZZPW-UHFFFAOYSA-N
MW510.97 g/mol
LogP5.42
Rot. Bonds5

About 5-chloro-N-[4-[[3-(2,4-difluorophenyl)-2-oxobenzimidazol-1-yl]methyl]cyclohexyl]-2-methylpyridine-3-carboxamide

5-chloro-N-[4-[[3-(2,4-difluorophenyl)-2-oxobenzimidazol-1-yl]methyl]cyclohexyl]-2-methylpyridine-3-carboxamide (PubChem CID 146172355) has the molecular formula C27H25ClF2N4O2 and a molecular weight of 510.97 g/mol. Its IUPAC name is 5-chloro-N-[4-[[3-(2,4-difluorophenyl)-2-oxobenzimidazol-1-yl]methyl]cyclohexyl]-2-methylpyridine-3-carboxamide.

Molecular Properties

Compound Name5-chloro-N-[4-[[3-(2,4-difluorophenyl)-2-oxobenzimidazol-1-yl]methyl]cyclohexyl]-2-methylpyridine-3-carboxamide
PubChem CID146172355
Molecular FormulaC27H25ClF2N4O2
Molecular Weight510.97 g/mol
Exact Mass510.16
IUPAC Name5-chloro-N-[4-[[3-(2,4-difluorophenyl)-2-oxobenzimidazol-1-yl]methyl]cyclohexyl]-2-methylpyridine-3-carboxamide
SMILESCc1ncc(Cl)cc1C(=O)NC1CCC(Cn2c(=O)n(-c3ccc(F)cc3F)c3ccccc32)CC1
InChIInChI=1S/C27H25ClF2N4O2/c1-16-21(12-18(28)14-31-16)26(35)32-20-9-6-17(7-10-20)15-33-24-4-2-3-5-25(24)34(27(33)36)23-11-8-19(29)13-22(23)30/h2-5,8,11-14,17,20H,6-7,9-10,15H2,1H3,(H,32,35)
InChIKeyFNWRGOIAYKZZPW-UHFFFAOYSA-N
XLogP5.42
TPSA68.92 Ų
H-Bond Donors1
H-Bond Acceptors5
Rotatable Bonds5
Heavy Atoms36
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500510.97
LogP ≤ 55.42
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 105

Analyze 5-chloro-N-[4-[[3-(2,4-difluorophenyl)-2-oxobenzimidazol-1-yl]methyl]cyclohexyl]-2-methylpyridine-3-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 5-chloro-N-[4-[[3-(2,4-difluorophenyl)-2-oxobenzimidazol-1-yl]methyl]cyclohexyl]-2-methylpyridine-3-carboxamide?
The IUPAC name of 5-chloro-N-[4-[[3-(2,4-difluorophenyl)-2-oxobenzimidazol-1-yl]methyl]cyclohexyl]-2-methylpyridine-3-carboxamide (CID 146172355) is 5-chloro-N-[4-[[3-(2,4-difluorophenyl)-2-oxobenzimidazol-1-yl]methyl]cyclohexyl]-2-methylpyridine-3-carboxamide.
What is the SMILES notation for 5-chloro-N-[4-[[3-(2,4-difluorophenyl)-2-oxobenzimidazol-1-yl]methyl]cyclohexyl]-2-methylpyridine-3-carboxamide?
The canonical SMILES for 5-chloro-N-[4-[[3-(2,4-difluorophenyl)-2-oxobenzimidazol-1-yl]methyl]cyclohexyl]-2-methylpyridine-3-carboxamide is Cc1ncc(Cl)cc1C(=O)NC1CCC(Cn2c(=O)n(-c3ccc(F)cc3F)c3ccccc32)CC1.
What is the InChIKey of 5-chloro-N-[4-[[3-(2,4-difluorophenyl)-2-oxobenzimidazol-1-yl]methyl]cyclohexyl]-2-methylpyridine-3-carboxamide?
The InChIKey is FNWRGOIAYKZZPW-UHFFFAOYSA-N. The full InChI is InChI=1S/C27H25ClF2N4O2/c1-16-21(12-18(28)14-31-16)26(35)32-20-9-6-17(7-10-20)15-33-24-4-2-3-5-25(24)34(27(33)36)23-11-8-19(29)13-22(23)30/h2-5,8,11-14,17,20H,6-7,9-10,15H2,1H3,(H,32,35).
What are the key properties of 5-chloro-N-[4-[[3-(2,4-difluorophenyl)-2-oxobenzimidazol-1-yl]methyl]cyclohexyl]-2-methylpyridine-3-carboxamide?
5-chloro-N-[4-[[3-(2,4-difluorophenyl)-2-oxobenzimidazol-1-yl]methyl]cyclohexyl]-2-methylpyridine-3-carboxamide has a molecular weight of 510.97 g/mol, XLogP of 5.42, 5 rotatable bonds, 1 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for 5-chloro-N-[4-[[3-(2,4-difluorophenyl)-2-oxobenzimidazol-1-yl]methyl]cyclohexyl]-2-methylpyridine-3-carboxamide is sourced from PubChem (CID 146172355), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).